HSTO Stock: Histogen Inc. Stock Price, Analysis & Insights
Get live HSTO stock price $0.02, comprehensive Histogen Inc. stock analysis, charts, news, and expert forecast. Real-time HSTO stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003,...
Company Information
- CEO
- Susan A. Knudson
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 7
Contact Information
- Website
- https://www.histogen.com
- Address
- 10655 Sorrento Valley Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Histogen Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Histogen Inc.
- ⚠Investors should consider how Histogen Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
85.44K
P/E Ratio (TTM)
-0.01
Beta
1.12
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare HSTO with peer companies:
- Price
- $2.11
- Market cap
- 45.72M
- Price
- $1.30
- Market cap
- 3.03M
- Price
- $0.07
- Market cap
- 778.33K
- Price
- $0.00
- Market cap
- 5.45K
- Price
- $0.02
- Market cap
- N/A
- Price
- $4.89
- Market cap
- 27.41M
- Price
- $0.43
- Market cap
- 5.69M
- Price
- $0.30
- Market cap
- 1.13M
- Price
- $61.56
- Market cap
- 477.80M
- Price
- $1.17
- Market cap
- 57.67M
- Price
- $0.24
- Market cap
- 4.17M
- Price
- $0.00
- Market cap
- 139
- Price
- $1.68
- Market cap
- 291.61M
- Price
- $0.01
- Market cap
- 114.70K
- Price
- $0.96
- Market cap
- 25.24M
- Price
- $1.26
- Market cap
- 8.43M
- Price
- $0.03
- Market cap
- 109.72K
- Price
- $0.34
- Market cap
- 1.18M
- Price
- $10.96
- Market cap
- 174.71M
- Price
- $1.27
- Market cap
- 5.64M
- Price
- $0.18
- Market cap
- 768.53K
- Price
- $1.02
- Market cap
- 192.09M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.